APGE
Price
$43.65
Change
+$0.66 (+1.54%)
Updated
Jun 26, 04:36 PM (EDT)
Capitalization
2.51B
67 days until earnings call
RCUS
Price
$8.54
Change
-$0.08 (-0.93%)
Updated
Jun 26, 04:24 PM (EDT)
Capitalization
912.73M
35 days until earnings call
Interact to see
Advertisement

APGE vs RCUS

Header iconAPGE vs RCUS Comparison
Open Charts APGE vs RCUSBanner chart's image
Apogee Therapeutics
Price$43.65
Change+$0.66 (+1.54%)
Volume$300
Capitalization2.51B
Arcus Biosciences
Price$8.54
Change-$0.08 (-0.93%)
Volume$718
Capitalization912.73M
APGE vs RCUS Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. RCUS commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Buy and RCUS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (APGE: $42.99 vs. RCUS: $8.62)
Brand notoriety: APGE and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 61% vs. RCUS: 107%
Market capitalization -- APGE: $2.51B vs. RCUS: $912.73M
APGE [@Biotechnology] is valued at $2.51B. RCUS’s [@Biotechnology] market capitalization is $912.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 5 TA indicator(s) are bullish while RCUS’s TA Score has 3 bullish TA indicator(s).

  • APGE’s TA Score: 5 bullish, 4 bearish.
  • RCUS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, APGE is a better buy in the short-term than RCUS.

Price Growth

APGE (@Biotechnology) experienced а +4.40% price change this week, while RCUS (@Biotechnology) price change was +1.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.99%. For the same industry, the average monthly price growth was +32.54%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

APGE is expected to report earnings on Sep 01, 2025.

RCUS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.51B) has a higher market cap than RCUS($913M). APGE YTD gains are higher at: -5.099 vs. RCUS (-42.109). APGE has higher annual earnings (EBITDA): -241.42M vs. RCUS (-377M). RCUS has more cash in the bank: 997M vs. APGE (513M). APGE has less debt than RCUS: APGE (11.8M) vs RCUS (60M). RCUS has higher revenues than APGE: RCUS (141M) vs APGE (0).
APGERCUSAPGE / RCUS
Capitalization2.51B913M275%
EBITDA-241.42M-377M64%
Gain YTD-5.099-42.10912%
P/E RatioN/AN/A-
Revenue0141M-
Total Cash513M997M51%
Total Debt11.8M60M20%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
44

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGERCUS
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 16 days ago
84%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
77%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFGIX19.40N/A
N/A
Fidelity Advisor Global Commodity Stk I
MRLOX18.76N/A
N/A
BlackRock Global Allocation R
DBOYX24.50N/A
N/A
BNY Mellon Balanced Opportunity Y
AIVGX19.31-0.05
-0.26%
American Funds International Vntg F-3
CRFAX11.63-0.08
-0.68%
Calvert Focused Value A